PenderFund Capital Management Ltd. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 19 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
PenderFund Capital Management Ltd. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$29,833
+42.9%
41,029,000
+30.9%
8.94%
+37.8%
Q2 2023$20,870
+112.4%
31,354,000
+79.6%
6.49%
+110.2%
Q1 2023$9,826
-38.1%
17,454,000
-17.3%
3.09%
-34.8%
Q4 2022$15,872
-99.9%
21,104,000
-28.9%
4.73%
-36.2%
Q3 2022$23,720,000
+11.0%
29,679,0000.0%7.42%
+25.6%
Q2 2022$21,367,000
+8.4%
29,679,0000.0%5.91%
+22.4%
Q1 2022$19,704,00029,679,0004.83%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2023
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 29,679,000$23,720,0007.42%
SILVERBACK ASSET MANAGEMENT LLC 11,750,000$6,487,1750.92%
DCF Advisers, LLC 1,550,000$884,0000.57%
Context Capital Management, LLC 14,764$8,274,0000.56%
AGF Investments LLC 7,000,000$3,872,0000.36%
WHITEBOX ADVISORS LLC 19,600,000$10,682,0000.30%
Pentwater Capital Management LP 46,411,000$26,134,0000.29%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$11,591,0000.27%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$13,275,0000.24%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 14,900,000$8,493,0000.12%
View complete list of ESPERION THERAPEUTICS INC NE shareholders